Scientists test direct tumor injection to boost cancer fight
NCT ID NCT03252938
Summary
This early-stage study is testing the safety and feasibility of new ways to deliver an immune-boosting drug called IMP321 to people with advanced solid tumors. Researchers are trying methods like injecting the drug directly into tumors or into the abdominal cavity, and combining it with standard cancer treatments. The goal is to see if these new delivery methods can help the immune system fight cancer more effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Agaplesion Markus Krankenhaus Frankfurter Diakonie Kliniken gGmbH
Frankfurt, 60431, Germany
-
Helios Dr. Horst Schmidt Klinikum Wiesbaden
Wiesbaden, 65199, Germany
-
Helios Klinikum Bad Saarow
Bad Saarow, 15526, Germany
-
Hämatologisch Onkologische Praxis Eppendorf (HOPE)
Hamburg, 20249, Germany
-
Kliniken der Stadt Köln gGmbH, Studienzentrum der Lungenklinik, Krankenhaus Merheim
Cologne, 51109, Germany
-
Krankenhaus Nordwest
Frankfurt, 60488, Germany
-
Marienhospital Herne, Klinik der Ruhr Universität Bochum, Klinik für Urologie
Herne, 44625, Germany
-
Universität Gießen und Marburg GmbH
Giessen, 35392, Germany
-
Universitätsklinikum Essen
Essen, 45147, Germany
-
Universitätsklinikum Tübingen
Tübingen, 72076, Germany
-
Universitätsklinikum Ulm, Early Clinical Trials Unit (ECTU)
Ulm, 89081, Germany
-
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, 55131, Germany
Conditions
Explore the condition pages connected to this study.